# Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer

> **NCT06080061** · PHASE1 · RECRUITING · sponsor: **Stanford University** · enrollment: 45 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **RADIATION:** Hypofractionated accelerated radiation therapy

## Key facts

- **NCT ID:** NCT06080061
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-25
- **Primary completion:** 2026-11
- **Final completion:** 2026-12
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06080061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06080061, "Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06080061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*